Arista Wealth Management LLC Makes New Investment in Lam Research Corporation $LRCX

Key Points

• Arista Wealth Management LLC has acquired a new stake in Lam Research Corporation, buying 17,661 shares valued at approximately $1,719,000 during the second quarter.
• Lam Research stock received positive attention from analysts, with several raising target prices and maintaining a high average rating of "Moderate Buy".
• The company recently increased its quarterly dividend from $0.23 to $0.26 per share, resulting in an annualized yield of 0.7%.

Arista Wealth Management LLC acquired a new stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 17,661 shares of the semiconductor company's stock, valued at approximately $1,719,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BankPlus Wealth Management LLC lifted its holdings in Lam Research by 2.0% in the second quarter. BankPlus Wealth Management LLC now owns 5,248 shares of the semiconductor company's stock worth $511,000 after purchasing an additional 105 shares during the period. ORG Partners LLC raised its position in shares of Lam Research by 7.3% during the 2nd quarter. ORG Partners LLC now owns 1,676 shares of the semiconductor company's stock worth $162,000 after buying an additional 114 shares in the last quarter. Fairvoy Private Wealth LLC raised its position in shares of Lam Research by 3.0% during the 2nd quarter. Fairvoy Private Wealth LLC now owns 4,185 shares of the semiconductor company's stock worth $407,000 after buying an additional 120 shares in the last quarter. Rosenberg Matthew Hamilton lifted its stake in shares of Lam Research by 16.0% in the 2nd quarter. Rosenberg Matthew Hamilton now owns 869 shares of the semiconductor company's stock worth $85,000 after acquiring an additional 120 shares during the period. Finally, Abundance Wealth Counselors boosted its holdings in shares of Lam Research by 1.1% in the second quarter. Abundance Wealth Counselors now owns 11,537 shares of the semiconductor company's stock valued at $1,123,000 after acquiring an additional 124 shares in the last quarter. Institutional investors and hedge funds own 84.61% of the company's stock.

Wall Street Analyst Weigh In

LRCX has been the topic of several recent analyst reports. Needham & Company LLC boosted their target price on Lam Research from $110.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, July 31st. Mizuho set a $162.00 price objective on Lam Research and gave the stock an "outperform" rating in a research note on Thursday. Summit Insights lowered Lam Research from a "buy" rating to a "hold" rating in a report on Thursday, July 31st. Argus lifted their target price on Lam Research from $105.00 to $120.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Finally, Cantor Fitzgerald upped their price target on shares of Lam Research from $155.00 to $170.00 and gave the company an "overweight" rating in a report on Tuesday. Twenty-three analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $125.08.

Insider Activity at Lam Research

In related news, SVP Vahid Vahedi sold 52,190 shares of the firm's stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the transaction, the senior vice president owned 251,047 shares of the company's stock, valued at approximately $34,870,428.30. This trade represents a 17.21% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.31% of the company's stock.

Lam Research Stock Down 1.7%

Shares of Lam Research stock opened at $142.37 on Friday. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $153.70. The firm has a market capitalization of $179.53 billion, a PE ratio of 34.22, a price-to-earnings-growth ratio of 1.76 and a beta of 1.84. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38. The stock's fifty day moving average is $118.26 and its 200-day moving average is $96.30.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, topping analysts' consensus estimates of $1.21 by $0.12. The firm had revenue of $5.17 billion for the quarter, compared to analysts' expectations of $4.99 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.Lam Research's revenue was up 33.6% on a year-over-year basis. During the same quarter last year, the business posted $1.03 EPS. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Equities analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, September 24th were issued a dividend of $0.26 per share. This is an increase from Lam Research's previous quarterly dividend of $0.23. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 24th. Lam Research's dividend payout ratio (DPR) is presently 25.00%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.